CC
BIO icon

Centiva Capital’s Bio-Rad Laboratories Class A BIO Stock Holding History

Centiva Capital’s Portfolio BIO Stock Details BIO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-1,508
Closed -$505K – 1715
2024
Q3 		$505K Buy
+1,508
New +$479K 0.02% 1242
2023
Q3 		– Sell
-755
Closed -$286K – 1727
2023
Q2 		$286K Buy
755
+18
+2% +$7.33K 0.01% 1145
2023
Q1 		$353K Buy
+737
New +$345K 0.02% 980
2022
Q2 		– Sell
-952
Closed -$536K – 1700
2022
Q1 		$536K Buy
+952
New +$574K 0.03% 945
2021
Q3 		– Sell
-1,124
Closed -$724K – 1289
2021
Q2 		$724K Buy
1,124
+756
+205% +$460K 0.06% 692
2021
Q1 		$210K Buy
+368
New +$218K 0.03% 954

Other funds holding BIO

BlackRock
BlackRock New York $5.7T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
VAM
Veritas Asset Management London, United Kingdom $5.9B AUM 3.19% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
VanEck Associates
VanEck Associates New York $133B AUM 72.99% 1-Year Est. Return
First Eagle Investment Management
First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
EARNEST Partners
EARNEST Partners Atlanta, Georgia $24.3B AUM 34.41% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $8.93B AUM 29.58% 1-Year Est. Return
Select Equity Group
Select Equity Group New York $18.8B AUM 17.33% 1-Year Est. Return